News
Despite securing a much-needed $5 million lifeline from an equity offering this week, HCW Biologics is continuing to warn ...
HCW Biologics Inc. (the "Company" or "HCW Biologics") (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing ...
Coya Therapeutics, Inc. ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announces that it will participate ...
Seasoned executive brings more than three decades of immunotherapy and drug discovery experiencePITTSBURGH, May 16, 2025 (GLOBE NEWSWIRE) -- BlueSphere Bio, a clinical stage drug development company ...
CHAI, a fast-rising AI startup in Palo Alto, is rapidly emerging as the next unicorn with explosive revenue growth of 250%, surpassing industry leaders like Databricks (127%), SpaceX (139%), and ...
FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on the development of therapeutics and potential cures ...
Is stress associated with Alzheimer's disease? It may be in women who are postmenopausal, a study led by The University of ...
21h
GlobalData on MSNAre regulators keeping pace with AI adoption in clinical trials?AI is increasingly being adopted by sponsors for various applications in clinical trials, including optimising trial design, ...
3h
Techno-Science.net on MSNArtificial intelligence and brain cancer 🧠While glioblastoma is a highly aggressive brain tumor that currently offers little hope of cure, researchers have managed to ...
13h
News-Medical.Net on MSNUnlocking live single-cell functional insightsDiscover how Bruker is advancing live single-cell functional analysis, helping to accelerate breakthroughs in immunology and ...
Science and society collaboration is essential for scientific progress, especially in the health and biomedical fields where ...
20h
Pharmaceutical Technology on MSNAGC Biologics and Quell to progress Treg cell therapy developmentThe Milan Cell and Gene Center of Excellence at AGC Biologics will produce LVV material for Treg cell therapy candidates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results